RECOMBIVAX HB
NDC 0006-4981, Hepatitis B Vaccine (Recombinant), injection, suspension, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-4981
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR, SUBCUTANEOUS
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA101066
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4981 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN5 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Hepatitis B Vaccines [CS]; Inactivated Hepatitis B Virus Vaccine [EPC]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-4981-00 | 00006498100 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4981-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4981-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0006-4981 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4981 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-4981. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.